Development
D
Cytokinetics, Incorporated CYTK
$36.16 -$0.42-1.15% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue 1.67M 378.00K 867.00K 4.61M 1.96M
Total Other Revenue -- -- -- -- 0.00
Total Revenue 1.67M 378.00K 867.00K 4.61M 1.96M
Cost of Revenue 84.98M 82.53M 83.19M 79.42M 75.02M
Gross Profit -83.30M -82.15M -82.33M -74.81M -73.06M
SG&A Expenses 44.11M 40.11M 39.72M 49.67M 53.97M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 129.09M 122.64M 122.92M 129.09M 128.99M
Operating Income -127.42M -122.27M -122.05M -124.47M -127.03M
Income Before Tax -136.90M -129.42M -128.64M -131.29M -137.38M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -136.90M -129.42M -128.64M -131.29M -137.38M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -136.90M -129.42M -128.64M -131.29M -137.38M
EBIT -127.42M -122.27M -122.05M -124.47M -127.03M
EBITDA -121.08M -120.41M -120.19M -122.63M -125.37M
EPS Basic -1.38 -1.35 -1.34 -1.38 -1.45
Normalized Basic EPS -0.86 -0.84 -0.84 -0.86 -0.91
EPS Diluted -1.38 -1.35 -1.34 -1.38 -1.45
Normalized Diluted EPS -0.86 -0.84 -0.84 -0.86 -0.91
Average Basic Shares Outstanding 99.07M 96.07M 95.76M 95.16M 94.68M
Average Diluted Shares Outstanding 99.07M 96.07M 95.76M 95.16M 94.68M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --